FORT LAUDERDALE, FL AND QUFU, CHINA, Dec 16, 2005 (MARKET WIRE via COMTEX) -- Sunwin International Neutraceuticals, Inc. (SUWN), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, has passed inspection at six manufacturing facilities. The Good Manufacturing Practice inspection ("GMP") was performed by the China Ministry of Agriculture. The inspections covered five veterinary medicine facilities and one Chinese herb facility.
 
The Chinese central government mandates manufacturers of Chinese herbs and veterinary medicines to comply with GMP standards by December 31, 2005. Currently, it is estimated that only one third of Chinese manufacturers in both industries are in compliance with the new mandate. Starting on January 1, 2006, only products manufactured within GMP certified facilities are available for sale in China.

Laiwang Zhang, Chairman and President of Sunwin, commented, "Sunwin has invested substantial capital to upgrade its manufacturing facilities in order to comply with the heightened standards mandated by the central government. The successful GMP inspection is a milestone for our company. Currently, we have 7 GMP certified manufacturing facilities that would accommodate substantial growth for the next 2 to 3 years for both veterinary medicine and Chinese herb medicine. We expect to witness a surge in demand for our products as much of our competition is currently unable to meet GMP standards."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. ("Sunwin") (SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevioside), and animal medicine prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.